Botox competitor awaits approval

By Katie Bird

- Last updated on GMT

Related tags Product Botulinum toxin Marketing Allergan

The FDA has agreed to evaluate an anti-wrinkle injection treatment
from France-based pharmaceutical company Ipsen which if approved
would provide a rival for Allergan's Botox.

The pharmaceutical giant dominates this market and Botox - its biggest selling product - is currently the only type A botulinum toxin product approved for aesthetic use in the US.

Growing market for non surgical procedures Last year sales of the product totalled $1.212 bn and the company has forecast increased sales for 2008.

Sales of the product for aesthetic use in 2007 increased by 29 per cent, whereas sales for other uses increased by only 19 per cent.

The market growth for cosmetics treatments shows no signs of abating and a possible competitor to Botox may stand much to gain from the growing popularity of non-surgical options such as this.

Awaiting FDA approval Ipsen's botulinum toxin product will be marketed under the tradename Reloxin if it is approved by the American regulatory authority.

Currently the treatment is approved for use in 23 countries including Australia, Brazil, Germany and Russia, and the company is looking to add other international markets to its portfolio.

On the acceptance of the dossier for review by the FDA, Ipsen's US partner Medicis paid the company $25m with the understanding that if the product is approved a further $75m will change hands before Medicis will commercialise the product in the US.

If the FDA approval goes ahead the product may be available in the second quarter of 2009, according to industry analysts.

If approved, Reloxin will be the first surgical product in Medicis' portfolio.

The company currently focuses on dermatological prescription products such as Restylane and Perlane, both based on hyarulonic acid.

Related news

Show more

Related products

show more

Get up to $500 off IGEN™ Non-GMO Tested Program!

Get up to $500 off IGEN™ Non-GMO Tested Program!

Content provided by SGS Nutrasource | 04-Jul-2024 | Insight Guide

The cosmetics industry has seen unprecedented growth in recent years, and with this growth comes a rising concern for what’s inside our everyday products.

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 07-Jun-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

Exosomes: Passing Trend or Transformative Reality?

Exosomes: Passing Trend or Transformative Reality?

Content provided by Naolys | 26-Mar-2024 | White Paper

Exosomes, microscopic vesicles naturally present in abundance within Plant Cells, have garnered significant attention within the scientific and cosmetic...

Related suppliers

Follow us

Products

View more

Webinars